Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Fear potentiation of the acoustic startle reflex was produced by eliciting startle responses in the presence of a light that had been previously paired with a shock. Buspirone (0.6-5.0 mg/kg) and gepirone (1.25-10.0 mg/kg), but not their common metabolite, 1-PP (0.5-40 mg/kg), produced a dose-dependent reduction of fear-potentiated startle. These doses of buspirone and gepirone slightly increased baseline startle levels. Reduction of fear-potentiated startle appears to involve supraspinal sites of action, since intraventricular but not intrathecal administration of buspirone (200 micrograms) reduced fear-enhanced startle. Both buspirone and gepirone were highly efficacious in this model compared to other animal tests that are used to study anxiolytic compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Buspirone is a mixed serotonergic agonist and dopamine D2 antagonist that has repeatedly been found to reduce the expression of fear-potentiated startle after acute administration (Kehne et al, 1988; Mansbach and Geyer, 1988), as well as light-enhanced startle (Walker and Davis, 1997a).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Kehne et al, 1988
Citations
The citation lists are queued
They are fetched later and appear here then.
References 33 · Cited by 93
Research works printed but not linked: 4
- Davis M, Astrachan DI, Kehne JH, Commissaris RL, Gallager DW (1984) Catecholamine modulation of sensorimotor reactivity measured with acoustic startle. In: Usdin E, Carlsson A, Dahlstrom A, Engel J (eds) Catecholamines: neuropharmacology and central nervous system ? theoretical aspects. Liss, New York, pp 245?258
- Gammons RE, Mayol RF, Eison MS (1983) Concentration of buspirone and 1-pyrimidinylpiperazine, a metabolite, in rat brain. Fed Proc 42:377
- Lucki I, Ward HR (1986) Antagonism of serotonin-mediated behaviors in rats by pretreatment with the nonbenzodiazepine anxiolytics buspirone or isapirone. Soc Neurosci Abstr 12:1236
- Reynolds LS, Seymour PA, Heym J (1986) Inhibition of the behavioral effects of 8-OH-DPAT by the novel anxiolytics buspirone, gepirone and isapirone. Soc Neurosci Abstr 12:481
Metadata
- Authors
- Kehne, J. H., Cassella, J. V., & Davis, M.
- Affiliations
- Yale University (US)
- ORCID
- Cassella, J. V.
- Venue
- Psychopharmacology
- Published
- 1988
- Volume
- 94
- Issue
- 1
- Pages
- 8-13
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2018081910
- Cited by
- 93
- References
- 33
- Citations by year
- 2025: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 2
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 25642, MH 00004)
- National Institute of Neurological Disorders and Stroke (NS-18033)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- buspirone, gepirone, anxiolytic effects, fear-potentiated startle, acoustic startle response, fear conditioning, intraventricular administration, intrathecal administration, supraspinal mechanisms, benzodiazepine metabolites
- MeSH terms
- Animals, Buspirone, Dose-Response Relationship, Drug, Fear, Injections, Intraventricular, Injections, Spinal, Male, Pyrimidines, Rats, Inbred Strains, Reflex, Startle, Anti-Anxiety Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. https://app.cochat.ai/papers/10.1007/bf00735872
- The paper
- Kehne, J. H., Cassella, J. V., & Davis, M. (1988). Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology. https://doi.org/10.1007/bf00735872
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.